Atlas Trials

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Clinical trial NCT07597941 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07597941
Sponsor
The Affiliated People's Hospital of Ningbo University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Promyelocytic Leukemia (APL)
Start date
2026-07-01
Primary completion
2028-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.